Caregivers & Loved Ones

How You Can Help

If your loved one has been diagnosed with EGFR-Positive Non-Small-Cell Lung Cancer, their journey may include a different path.

Caring for a loved one with non-small-cell lung cancer (NSCLC), means you are experiencing cancer alongside them. It is natural to feel tired, or worried, or even overwhelmed.

As a loved one, you are a partner, a friend, a health aid, an advocate, and you may be highly involved in the decision-making process when it comes to potential options. Therefore, it is important that you are informed of the potential options that may be available to you and your loved one.

Until recently most NSCLC were treated similarly, with therapies that destroy dividing cells (both cancer and healthy cells alike). Today, clinical research studies are evaluating the safety and efficacy of investigational medications (with the goal of targeting certain mutations) to potentially treat NSCLC.

Research studies are currently being conducted on investigational medications specifically for NSCLC that tests positive for mutations to a protein called epidermal growth factor receptor (EGFR). If your loved one has NSCLC that is EGFR-positive, they may be able to take part in one of these studies.

Here’s how you can help:
Share

Share this website with your loved one and encourage them to learn about these research studies.

Share This
Encourage Contact

Have your loved one contact our nurses to ask any questions they may have and see if they may qualify to participate in a certain study.

Call 1800 860 819
Download Brochure

Download a patient brochure
with more information on the Papillon Study that you can share with your loved one.

Speak to a Doctor

Encourage your loved one to speak with their doctor about biomarker testing, gene mutations & clinical research study participation. You can download a discussion guide to help foster the conversation between your loved one and their physician.

Download Discussion Guide
Scroll to learn more about EGFR-positive NSCLC.
FAQs
What is EGFR-positive NSCLC?

EGFR-positive NSCLC is NSCLC that tests positive for a mutation in the gene that produces a protein called epidermal growth factor receptor, or EGFR. EGFR is involved in cell growth and cell survival. When it mutates, it can cause cancer cells to grow and spread in the body.1 There are both common and rare EGFR mutations.

  • An example of a rare EGFR mutation is the Exon 20 insertion, which accounts for a small proportion of the NSCLC population2
  • More common EGFR mutations (85%-90%) are Exon 19 deletion and Exon 21 L858R substitution2
What are some options for EGFR-positive NSCLC?

Research studies are currently being conducted on investigational medications that specifically aim to target mutations in the gene that creates EGFR. If your loved one has NSCLC that is EGFR-positive, they may be able to take part in one of these studies.

Your loved one can learn more about the studies and see if they may be eligible by visiting this page.

How do we know if NSCLC is EGFR-Positive?

Once NSCLC is diagnosed, a biomarker test (sometimes called a "gene test" or "molecular test") may be given to find out which gene mutation, such as a mutation to EGFR, is causing the disease. NSCLC with certain mutations are currently being studied in clinical research studies and this test can be an important tool for determining eligibility and choosing potential options.3

If your loved one does not know if they are EGFR-positive, it’s important to ask whether they should get tested.

You can download a discussion guide here for information you can use during your next conversation with the doctor.

Visit this page to learn more about Biomarker Testing.

If you have EGFR-Positive Non-Small-Cell Lung Cancer, your journey may include a different path. 

The more we learn, the farther we can go.

See If You Are Eligible